CERo Therapeutics Holdings, Inc. (CERO)

Market Cap	1.02M -83.6%
Revenue (ttm)	n/a
Net Income	-49.19M
EPS	-98.71
Shares Out	29.93M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	220,490
Average Volume	616,879
Open	0.0341
Previous Close	0.0341
Day's Range	0.0340 - 0.0399
52-Week Range	0.0340 - 30.8000
Beta	0.32
RSI	30.40
Earnings Date	Mar 23, 2026

About CERO

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2021
• Employees: 8
• Stock Exchange: OTCMKTS
• Ticker Symbol: CERO